Cabotegravir (CAB)

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Gilead Sciences

Conditions

HIV InfectionsTuberculosis

Unknown Phase

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

CompletedNCT04518228

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Tuberculosis

Start: 2021-09-01End: 2025-07-10Updated: 2025-11-12

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

RecruitingNCT07473778

Gilead SciencesHIV Infections

Start: 2026-03-17End: 2029-04-01Target: 3000Updated: 2026-04-03